Abstract
Amyloid beta peptide (Aβ) is implicated in the pathogenesis of Alzheimers disease (AD), particularly as oligomers or polymers that are correlated with Ab cellular toxicity. Inhibition of the formation of toxic forms of Aβ has therefore emerged as one approach to the treatment of AD. This article reviews efforts to adapt the structure of Aβ to the design and testing of peptide-based inhibitors of Aβ polymerization of interest as potential AD therapeutics.
Keywords: Peptide Inhibitors, Beta Amyloid Aggregation, Amyloid beta peptide
Current Topics in Medicinal Chemistry
Title: Peptide Inhibitors of Beta Amyloid Aggregation
Volume: 2 Issue: 4
Author(s): Mark A. Findeis
Affiliation:
Keywords: Peptide Inhibitors, Beta Amyloid Aggregation, Amyloid beta peptide
Abstract: Amyloid beta peptide (Aβ) is implicated in the pathogenesis of Alzheimers disease (AD), particularly as oligomers or polymers that are correlated with Ab cellular toxicity. Inhibition of the formation of toxic forms of Aβ has therefore emerged as one approach to the treatment of AD. This article reviews efforts to adapt the structure of Aβ to the design and testing of peptide-based inhibitors of Aβ polymerization of interest as potential AD therapeutics.
Export Options
About this article
Cite this article as:
Findeis A. Mark, Peptide Inhibitors of Beta Amyloid Aggregation, Current Topics in Medicinal Chemistry 2002; 2 (4) . https://dx.doi.org/10.2174/1568026024607508
DOI https://dx.doi.org/10.2174/1568026024607508 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
Drug Discovery in the Age of Artificial Intelligence
In the age of artificial intelligence (AI), we have witnessed a significant boom in AI techniques for drug discovery. AI techniques are increasingly integrated and accelerating the drug discovery process. These developments have not only attracted the attention of academia and industry but also raised important questions regarding the selection ...read more
From Biodiversity to Chemical Diversity: Focus of Flavonoids
Flavonoids are the largest group of polyphenols, plant secondary metabolites arising from the essential aromatic amino acid phenylalanine (or more rarely from tyrosine) via the phenylpropanoid pathway. The flavan nucleus is the basic 15-carbon skeleton of flavonoids (C6-C3-C6), which consists of two phenyl rings (A and B) and a heterocyclic ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
MIIP, a Cytoskeleton Regulator that Blocks Cell Migration and Invasion, Delays Mitosis, and Suppresses Tumorogenesis
Current Protein & Peptide Science New Perspectives of Infections in Cardiovascular Disease
Current Cardiology Reviews Gene Therapy Approaches in an Autoimmune Demyelinating Disease: Multiple Sclerosis
Current Gene Therapy Substrates, Inhibitors and Activators of P-glycoprotein: Candidates for Radiolabeling and Imaging Perspectives
Current Topics in Medicinal Chemistry Child and Adolescent Refugee Mental Health in Brazil: Literature Review and a Family Case Report
Adolescent Psychiatry Altering Outcomes in Juvenile Offending: The Evidence Base
Adolescent Psychiatry Speciation of Metal Complexes of Medicinal Interest: Relationship between Solution Equilibria and Pharmaceutical Properties
Current Medicinal Chemistry Editorial (Application of a Multidisciplinary Approach to Alzheimers Disease to Develop Novel Drug Targets by Integrating Biomarkers, Imaging, Genetic and Molecular Strategies)
Current Alzheimer Research Development of Thiadiazole as an Antidiabetic Agent- A Review
Mini-Reviews in Medicinal Chemistry Fetuin-A: A Multifunctional Protein
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Development of Monoamine Oxidase B Inhibitors with Antiparkinson Activity
Current Physical Chemistry Soluble Amyloid-β Levels and Late-Life Depression
Current Pharmaceutical Design Genetic Determinants of Vitamin D-Related Disorders; Focus on Vitamin D Receptor
Current Drug Metabolism Linkage of Stress with Neuromuscular Disorders
CNS & Neurological Disorders - Drug Targets Safety Considerations of the Use of Second Generation Antipsychotics in the Treatment of Major Depression: Extrapyramidal and Metabolic Side Effects
Current Drug Safety Macrophage-Assisted Inflammation and Pharmacological Regulation of the Cholinergic Anti-Inflammatory Pathway
Current Medicinal Chemistry Bone Marrow-Derived Mesenchymal Stem Cells Contribute to the Reduction of Amyloid-β Deposits and the Improvement of Synaptic Transmission in a Mouse Model of Pre-Dementia Alzheimer’s Disease
Current Alzheimer Research ROS1 Kinase Inhibitors for Molecular-Targeted Therapies
Current Medicinal Chemistry Pharmacophore Modeling, 3D-QSAR and Molecular Docking of Furanochalcones as Inhibitors of Monoamine Oxidase-B
Central Nervous System Agents in Medicinal Chemistry Engineered Polymer Nanoplatforms for Targeted Tumor Cells and Controlled Release Cargos to Enhance Cancer Treatment
Current Medicinal Chemistry